Cyclic derivatives as modulators of chemokine receptor activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S237200, C514S254010, C514S326000, C514S422000, C544S141000, C544S372000, C546S208000, C548S518000, C548S953000

Reexamination Certificate

active

11545584

ABSTRACT:
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.

REFERENCES:
patent: 5356907 (1994-10-01), Clemence et al.
patent: 6011052 (2000-01-01), Padia et al.
patent: 6706712 (2004-03-01), Cherney
patent: 7183270 (2007-02-01), Cherney et al.
patent: 2003/0060459 (2003-03-01), Cherney et al.
patent: 2003/0216434 (2003-11-01), Cherney
patent: 2004/0110736 (2004-06-01), Cherney
patent: 2004/0186143 (2004-09-01), Carter et al.
patent: 2004/0235835 (2004-11-01), Carter
patent: 2004/0235836 (2004-11-01), Cherney
patent: WO 97/37975 (1997-10-01), None
patent: WO 97/44329 (1997-11-01), None
patent: WO 98/06703 (1998-02-01), None
patent: WO 98/08826 (1998-03-01), None
patent: WO 99/07351 (1999-02-01), None
patent: WO 99/07678 (1999-02-01), None
patent: WO 99/25686 (1999-05-01), None
patent: WO 9937304 (1999-07-01), None
patent: WO 99/40913 (1999-08-01), None
patent: WO 99/40914 (1999-08-01), None
patent: WO 00/46196 (2000-08-01), None
patent: WO 00/69815 (2000-11-01), None
patent: WO 00/69820 (2000-11-01), None
patent: WO 01/19939 (2001-03-01), None
patent: WO 02/04416 (2002-01-01), None
patent: WO 02/26734 (2002-04-01), None
patent: WO 02/50019 (2002-06-01), None
patent: WO 02/060859 (2002-08-01), None
patent: WO 02060859 (2002-08-01), None
patent: WO 02/075023 (2002-09-01), None
patent: WO 02/102372 (2002-12-01), None
patent: WO 03/43988 (2003-05-01), None
patent: WO 03075853 (2003-09-01), None
patent: WO 2004071449 (2004-08-01), None
patent: WO 2004098512 (2004-11-01), None
patent: WO 2004098516 (2004-11-01), None
Suga et al., “Glycosidase Antibodies Induced to Half-Chair Transition-State Analog,”J. Am. Chem. Soc., vol. 116, pp. 11197-11198, 1994.
Fujita et al., “Regiocontrolled Iodoaminocyclization Reaction of an Ambident Nucleophile Mediated by Basic Metallic Reagent,”J. Org. Chem., vol. 62 pp. 7330-7335, 1997.
Evans et al., “Synthesis and Dopamine Receptor Modulating Activity of Novel Peptidomimetics of L-Propyl-L-Leucyl-Glycinamide Featuring Alpha, Alpha-Di-substited Amino Acids”, Am. Chem. Soc., vol. 42, 1999, pp. 1441-1447.
U.S. Appl. No. 10/922,406, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,619, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/922,726, filed Aug. 19, 2004, Carter et al.
U.S. Appl. No. 10/923,538, filed Aug. 19, 2004, Carter et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cyclic derivatives as modulators of chemokine receptor activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic derivatives as modulators of chemokine receptor activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic derivatives as modulators of chemokine receptor activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3952021

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.